Literature DB >> 17236393

Flow-cytometric identification, enumeration, purification, and expansion of CD133+ and VEGF-R2+ endothelial progenitor cells from peripheral blood.

P Rustemeyer1, W Wittkowski, B Greve, M Stehling.   

Abstract

A flow cytometric method for identifying, purifying, and expanding endothelial progenitor cells (EPC) derived from peripheral blood is reported. During our experiments, we found that isolation of viable EPC is not possible by using the standard flow cytometric protocols, since erythrocyte lysing influences cell survival. Furthermore, erythrocyte lysing has a high impact on quantative analysis of EPC with 20% lower numbers compared to no-lyse data. The viability of EPCs was tested with a colony forming test after both lysis based FACS of EPCs and without lysing. CD133 and VEGF-R2 revealed as positive markers for EPC selection and 7-amino actinomycin D (7-AAD) to eliminate dead cells. The few purified CD133+ and VEGF-R2+ cells showed strong colony-forming capacity in a human stem cell methylcellulose based medium (colony assay) when isolated by the no-lyse protocol. The colonies showed the typical shape of early EPC-colonies with round immature cells in the centre and dendritic or spindelcell-shaped peripheral cells, which were also immunologically identified as EPC-derived. Compared to this, erythrocyte lysing reagents destroyed even all sorted EPCs. Summarizing the presented data suggest that the use of erythrocyte lysing reagents is neither suitable for cloning nor for counting of endothelial progenitor cells, and no-lyse protocols should be used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236393     DOI: 10.1080/15321810601025549

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  8 in total

1.  Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Thuy Thi-Thanh Dao; Ha Thi-Ngan Le; Lan Thi Phi; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-24       Impact factor: 2.416

Review 2.  Therapeutic angiogenesis in critical limb ischemia.

Authors:  Geoffrey O Ouma; Barak Zafrir; Emile R Mohler; Moshe Y Flugelman
Journal:  Angiology       Date:  2012-11-04       Impact factor: 3.619

3.  Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.

Authors:  Ali S Arbab; Branislava Janic; Robert A Knight; Stasia A Anderson; Edyta Pawelczyk; Ali M Rad; Elizabeth J Read; Sunil D Pandit; Joseph A Frank
Journal:  FASEB J       Date:  2008-06-12       Impact factor: 5.191

4.  Circulating endothelial progenitor cells in kidney transplant patients.

Authors:  Giovana S Di Marco; Peter Rustemeyer; Marcus Brand; Raphael Koch; Dominik Kentrup; Alexander Grabner; Burkhard Greve; Werner Wittkowski; Hermann Pavenstädt; Martin Hausberg; Stefan Reuter; Detlef Lang
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

5.  Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.

Authors:  Hon-Kan Yip; Tzu-Hsien Tsai; Hung-Sheng Lin; Shu-Fang Chen; Cheuk-Kwan Sun; Steve Leu; Chun-Man Yuen; Teng-Yeow Tan; Min-Yu Lan; Chia-Wei Liou; Cheng-Hsien Lu; Wen-Neng Chang
Journal:  Crit Care       Date:  2011-01-26       Impact factor: 9.097

6.  CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma.

Authors:  Kai Liu; Meijun Hao; Yabo Ouyang; Jiasheng Zheng; Dexi Chen
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

7.  Increased carotid intima-media thickness and reduced distensibility in human class III obesity: independent and differential influences of adiposity and blood pressure on the vasculature.

Authors:  Xiao L Moore; Danielle Michell; Sabrina Lee; Michael R Skilton; Rajesh Nair; John B Dixon; Anthony M Dart; Jaye Chin-Dusting
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

Review 8.  Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder.

Authors:  Rashmi K Ambasta; Harleen Kohli; Pravir Kumar
Journal:  J Transl Med       Date:  2017-08-31       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.